| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |